ConductScience.org, home

Comparison · NCT02084134-2fe7cb60

Steroid Treatment Arm vs Non-steroid Treatment: Number of Participants With Adrenal Insufficiency

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Steroid Treatment Arm vs Non-steroid Treatment: Number of Participants With Adrenal Insufficiency. Trial comparisons, record NCT02084134-2fe7cb60. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02084134-2fe7cb60

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1050.02940.314wilson
Risk in group 20.05880.01050.27wilson
Risk difference, group 1 minus group 20.0464-0.1780.261newcombe hybrid score
Risk ratio, group 1 over group 21.790.17818log
Odds ratio, group 1 over group 21.880.15522.8log
Number needed to treat, for one more participant with the outcome on Steroid Treatment Arm than on Non-steroid Treatment21.5from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Steroid Treatment Arm
Receives intravenous hydrocortisone 100mg and following surgery intravenous dexamethasone 0.5mg~hydrocortisone: 100mg at the time of surgery~dexamethasone: 0.5mg every 6 hours for a total of four doses
219OG000
Group 2Non-steroid TreatmentSubjects will not receive any steroids at the time of surgery or after surgery unless symptoms of adrenal insufficiency develop (i.e. nausea, vomiting, dizziness, or low blood pressure).117OG001

Outcome

Type
PRIMARY
Title
Number of Participants With Adrenal Insufficiency
Description
Adrenal insufficiency was defined by a 30 or 60 min cortisol \< 18 during a cosyntropin stimulation test
Time frame
6 weeks following surgery
Population

Source ClinicalTrials.gov

Trial

Title
Peri-Operative Steroid Management in Patients
NCT number
NCT02084134
Phases
NA
Conditions
Pituitary Adenoma, Pituitary Diseases
Interventions
hydrocortisone, dexamethasone
Lead sponsor
Washington University School of Medicine
Results first posted
2018-03-01

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02084134-2fe7cb60